Page last updated: 2024-08-24

topotecan and Diffuse Large B-Cell Lymphoma

topotecan has been researched along with Diffuse Large B-Cell Lymphoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cassileth, PA; Gordon, LI; Habermann, TM; Hochster, HS; Horning, SJ; Li, H; Minniti, CJ; Nazeer, T; Shapiro, GR; Weller, E; Wiernik, PH	1

Other Studies

1 other study(ies) available for topotecan and Diffuse Large B-Cell Lymphoma

Article	Year
Activity of topotecan 21-day infusion in patients with previously treated large cell lymphoma: long-term follow-up of an Eastern Cooperative Oncology Group study (E5493). Leukemia & lymphoma, 2012, Volume: 53, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Infusion Pumps; Lymphoma, Large B-Cell, Diffuse; Male; Medical Oncology; Middle Aged; Retrospective Studies; Societies, Medical; Time Factors; Topotecan; Treatment Outcome; United States; Young Adult	2012

Article

Year

Activity of topotecan 21-day infusion in patients with previously treated large cell lymphoma: long-term follow-up of an Eastern Cooperative Oncology Group study (E5493).

Leukemia & lymphoma, 2012, Volume: 53, Issue:6

Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Infusion Pumps; Lymphoma, Large B-Cell, Diffuse; Male; Medical Oncology; Middle Aged; Retrospective Studies; Societies, Medical; Time Factors; Topotecan; Treatment Outcome; United States; Young Adult

2012